IL149669A0 - NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS - Google Patents

NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS

Info

Publication number: IL149669A0
Authority: IL; Israel
Prior art keywords: dioxino; neuroleptics; benzylamino; indol; tetrahydro
Prior art date: 1999-12-10

Application number

IL14966900A

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-10

Filing date

2000-12-07

Publication date

2002-11-10

2000-12-07 Application filed by Wyeth Corp filed Critical Wyeth Corp

2002-11-10 Publication of IL149669A0 publication Critical patent/IL149669A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

IL14966900A 1999-12-10 2000-12-07 NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS IL149669A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45860799A	1999-12-10	1999-12-10
PCT/US2000/033060 WO2001041750A2 (en)	1999-12-10	2000-12-07	Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (1)

Publication Number	Publication Date
IL149669A0 true IL149669A0 (en)	2002-11-10

Family

ID=23821437

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14966900A IL149669A0 (en)	1999-12-10	2000-12-07	NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
IL149669A IL149669A (en)	1999-12-10	2002-05-15	THERAPEUTIC COMBINATIONS OF (S)-2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL149669A IL149669A (en)	1999-12-10	2002-05-15	THERAPEUTIC COMBINATIONS OF (S)-2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS

Country Status (20)

Country	Link
EP (1)	EP1235570A2 (en)
JP (1)	JP5557409B2 (en)
KR (1)	KR100772854B1 (en)
CN (1)	CN1230164C (en)
AR (1)	AR026756A1 (en)
AU (1)	AU784211B2 (en)
BR (1)	BR0016168A (en)
CA (1)	CA2396351C (en)
CZ (1)	CZ20021880A3 (en)
EA (1)	EA005002B1 (en)
HK (1)	HK1045942A1 (en)
HU (1)	HUP0203309A3 (en)
IL (2)	IL149669A0 (en)
MX (1)	MXPA02005649A (en)
NO (1)	NO20022739L (en)
NZ (1)	NZ519381A (en)
PL (1)	PL355292A1 (en)
TW (1)	TWI222864B (en)
WO (1)	WO2001041750A2 (en)
ZA (1)	ZA200205484B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102335116A (en)	2003-10-29	2012-02-01	惠氏有限责任公司	Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
US7297704B2 (en)	2005-02-17	2007-11-20	Wyeth	Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives
WO2009102962A2 (en) *	2008-02-13	2009-08-20	Targacept, Inc.	Combination of alpha 7 nicotinic agonists and antipsychotics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2987484B2 (en) *	1995-03-16	1999-12-06	大塚製薬株式会社	Method for producing carbostyril derivative
US5756532A (en) *	1995-11-06	1998-05-26	American Home Products Corporation	Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) *	1996-12-27	1997-02-12	Knoll Ag	Therapeutic agents

2000
- 2000-12-07 EA EA200200656A patent/EA005002B1/en not_active IP Right Cessation
- 2000-12-07 WO PCT/US2000/033060 patent/WO2001041750A2/en active IP Right Grant
- 2000-12-07 CZ CZ20021880A patent/CZ20021880A3/en unknown
- 2000-12-07 NZ NZ519381A patent/NZ519381A/en unknown
- 2000-12-07 KR KR1020027007286A patent/KR100772854B1/en not_active IP Right Cessation
- 2000-12-07 HU HU0203309A patent/HUP0203309A3/en unknown
- 2000-12-07 IL IL14966900A patent/IL149669A0/en active IP Right Grant
- 2000-12-07 MX MXPA02005649A patent/MXPA02005649A/en active IP Right Grant
- 2000-12-07 CA CA002396351A patent/CA2396351C/en not_active Expired - Lifetime
- 2000-12-07 EP EP00982461A patent/EP1235570A2/en not_active Withdrawn
- 2000-12-07 BR BR0016168-3A patent/BR0016168A/en not_active Application Discontinuation
- 2000-12-07 AR ARP000106504A patent/AR026756A1/en unknown
- 2000-12-07 CN CNB008169527A patent/CN1230164C/en not_active Expired - Lifetime
- 2000-12-07 AU AU19490/01A patent/AU784211B2/en not_active Ceased
- 2000-12-07 PL PL00355292A patent/PL355292A1/en not_active Application Discontinuation
- 2000-12-07 JP JP2001543095A patent/JP5557409B2/en not_active Expired - Lifetime
- 2000-12-08 TW TW089126071A patent/TWI222864B/en not_active IP Right Cessation
2002
- 2002-05-15 IL IL149669A patent/IL149669A/en not_active IP Right Cessation
- 2002-06-07 NO NO20022739A patent/NO20022739L/en not_active Application Discontinuation
- 2002-07-09 ZA ZA200205484A patent/ZA200205484B/en unknown
- 2002-10-09 HK HK02107378.5A patent/HK1045942A1/en unknown

Also Published As

Publication number	Publication date
HUP0203309A3 (en)	2004-12-28
AR026756A1 (en)	2003-02-26
EA005002B1 (en)	2004-10-28
JP5557409B2 (en)	2014-07-23
WO2001041750A2 (en)	2001-06-14
ZA200205484B (en)	2003-12-31
HK1045942A1 (en)	2002-12-20
TWI222864B (en)	2004-11-01
EP1235570A2 (en)	2002-09-04
NO20022739D0 (en)	2002-06-07
PL355292A1 (en)	2004-04-05
WO2001041750A3 (en)	2002-02-14
CN1409633A (en)	2003-04-09
BR0016168A (en)	2002-08-20
NZ519381A (en)	2004-04-30
NO20022739L (en)	2002-06-07
EA200200656A1 (en)	2002-12-26
KR20030016207A (en)	2003-02-26
CZ20021880A3 (en)	2002-08-14
CA2396351A1 (en)	2001-06-14
JP2003516350A (en)	2003-05-13
AU784211B2 (en)	2006-02-23
CA2396351C (en)	2009-11-10
IL149669A (en)	2006-06-11
AU1949001A (en)	2001-06-18
KR100772854B1 (en)	2007-11-02
MXPA02005649A (en)	2004-09-10
CN1230164C (en)	2005-12-07
HUP0203309A2 (en)	2003-01-28

Similar Documents

Publication	Publication Date	Title
AU2604301A (en)	2001-07-16	Tnf inhibitors for the treatment of neurological, retinal and muscular disorders
AU6530600A (en)	2001-03-05	Use of neurotoxin for treating cardiac muscle disorders
HUP9700603A3 (en)	2001-08-28	Pharmaceutical preparation for the treatment of blood coagulation disorders
AU3112899A (en)	1999-10-18	Rf diathermy and faradic muscle stimulation treatment
HUP0100069A3 (en)	2002-04-29	4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HK1046274A1 (en)	2003-01-03	Spiro Ä1-azabicycloÄ2.2.2.Üoctane-3,2'(3'h)-furoÄ2,3-bÜpyridine for use in the treatment of psychotic and intellectual impairment disorders.
HUP0103839A3 (en)	2004-06-28	Use of certain drugs for treating nerve root injury
PL344304A1 (en)	2001-10-22	Combination therapy for treatment of bipolar disorders
EP1063990A4 (en)	2003-01-02	Therapy of estrogen-associated disorders
IL127943A0 (en)	1999-11-30	Pharmaceutical and cosmetic composition for the treatment of skin disorders
EP1191941A4 (en)	2006-12-13	A method for the prophylaxis and/or treatment of medical disorders
AU2001256855A1 (en)	2001-11-20	Preparation for the prevention and treatment of ocular disorders
EP1126850A4 (en)	2003-01-15	Treatment of disorders of the outer retina
AU1546101A (en)	2001-05-30	Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
HUP0102436A3 (en)	2002-01-28	Use of reboxetin for preparation of medicament for nervous disorders
AU7601400A (en)	2001-04-24	Treatment and prevention of hepatic disorders
AU7106300A (en)	2001-04-10	Treatment of skin disorders
IL149669A0 (en)	2002-11-10	NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
AU3338699A (en)	1999-10-18	Medical devices treated to discourage blood coagulation
GB2370507B (en)	2003-07-30	Apparatus for the diagnosis and therapy of neuro-muscular and other tissue disorders
PL347976A1 (en)	2002-05-06	Isonipecotamides for the treatment of integrin−mediated disorders
AU2002348324A1 (en)	2003-05-12	Methods and compositions for the treatment and diagnosis of pain disorders using 46566
AU1399100A (en)	2000-06-19	Therapeutic treatment with immunogenic drugs
GC0000176A (en)	2006-03-29	Pharmaceutical combination preparations for the treatment of cardiac disorders
AU2002360318A1 (en)	2003-05-12	Methods and compositions for the treatment and diagnosis of pain disorders using 9805

Legal Events

Date	Code	Title
2006-12-07	FF	Patent granted
2006-12-27	KB	Patent renewed
2007-02-12	KB	Patent renewed